PDS Biotechnology Corpora... (PDSB)
1.21
-0.12 (-9.02%)
At close: Mar 03, 2025, 12:44 PM
PDS Biotechnology Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -3.58 | -9.24 | -12.26 | -2.41 | -1.84 | -0.25 | -5.6 | -9.29 | -3.6 | -13.62 | -24.14 | -66.95 |
| PEG Ratio | 1.28 | -0.08 | 0.47 | 0.06 | 0.02 | 0.01 | -0.23 | 0.15 | -0.01 | -0.18 | -0.14 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 5.89 | 8.58 | 3.28 | 1.32 | 1.10 | 0.34 | 4.57 | 4.04 | 0.83 | -5.97 | -10.83 | -92.94 |
| P/FCF Ratio | -4.57 | -14.68 | -16.61 | -2.73 | -0.71 | -0.3 | -6.97 | -10.97 | -4.38 | -15.68 | -20.31 | -139.99 |
| P/OCF Ratio | -4.57 | -14.68 | -16.61 | -2.73 | -0.71 | -0.3 | -7 | -11.21 | -4.65 | -17.1 | -20.66 | -140.03 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.91 | 0.53 | 0.01 | 0.02 | n/a | 0.00 | 0.33 | 0.17 | 0.04 | -0.1 | n/a | -0.06 |
| Quick Ratio | 4.33 | 7.79 | 17.80 | 9.28 | 5.18 | 5.59 | 6.92 | 16.06 | 15.28 | 3.97 | 4.77 | 0.04 |
| Current Ratio | 4.33 | 7.79 | 17.80 | 9.28 | 5.18 | 5.59 | 6.92 | 16.06 | 15.28 | 3.97 | 4.77 | 0.04 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -10.23 | -31.65 | n/a | n/a | -626.8 | -30.24 | -23.84 | -32.83 | -32.45 | -72.03 | -1.93K | -1.77K |
| Return on Equity (ROE) | -1.64 | -0.93 | -0.27 | -0.55 | -0.6 | -1.37 | -0.82 | -0.43 | -0.23 | 0.44 | 0.45 | 1.39 |
| Return on Assets (ROA) | -0.72 | -0.53 | -0.25 | -0.48 | -0.48 | -1.13 | -0.55 | -0.35 | -0.21 | -0.72 | -0.79 | -28.69 |
| Return on Capital (ROIC) | -0.94 | -0.62 | -0.34 | -0.54 | -1.8 | -1.44 | -0.65 | -0.38 | -0.21 | -1 | -0.93 | 1.40 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |